Sickle Cell Research Meeting Schedule
The Sickle Cell Meeting is held on selected TUESDAYs at 3:30pm via Zoom, unless otherwise noted. To listen to presentations and view the slides of past talks, CLICK HERE.
For more information about this conference, please contact Dr. Enrico Novelli.
2021 | ||
---|---|---|
January 26 | Tomasz Brzoska, M Pharm, PhD Purinergic signaling-dependent platelet activation associated with acute versus chronic hemolysis | Laura DeCastro, MD, MHSc Sickle Cell Disease and COVID 19 infection, an update |
February 23 | Katherine Wood, PhD Cytochrome b5 reductase 3 is a resilience factor in mice with sickle cell disease, modifying the brain-blood axis response to ischemic stroke | |
March 30 | Darrell Triulzi MD The Sickle Cell Disease Cardiovascular Risk: Red Cell Exchange Trial (SCD CARRE) | Maureen Mburu, MD Nonhematopoietic Nrf2 Deficiency Worsens Chronic Intravascular Hemolysis but not Cardiomyopathy in Transgenic Sickle Cell Mice |
April 27 | Samit Ghosh, PhD Peritubular Endothelium: an important piece of the CKD jigsaw in SCD | Bethany Flage, MS The role of hemoglobin variants in Plasmodium falciparum sexual differentiation |
May 25 | Deirdre Nolfi-Donegan, MD Hypercoagulability in Sickle Cell Disease: Linking Hemolysis to Thrombosis | |
June 29 | Rimi Hazra, PhD Vasculo-Neuronal Interactions in Sickle Cell Disease |